| 商品名称 | 适用类别 | 通用名称 | 活性成分 | 产品号 | 上市许可开发者/申请人/持有人 | 上市许可日期 | 许可状态 |
|---|---|---|---|---|---|---|---|
| Afqlir | Human | aflibercept | aflibercept | EMEA/H/C/006150 | Sandoz GmbH | 2024/11/13 | Authorised |
| Opuviz | Human | aflibercept | aflibercept | EMEA/H/C/006056 | Samsung Bioepis NL B.V. | 2024/11/13 | Authorised |
| Yuvanci | Human | macitentan;tadalafil | macitentan;tadalafil | EMEA/H/C/005001 | Janssen-Cilag International NV | 2024/09/27 | Authorised |
| Otulfi | Human | ustekinumab | ustekinumab | EMEA/H/C/006544 | Fresenius Kabi Deutschland GmbH | 2024/09/25 | Authorised |
| Fymskina | Human | ustekinumab | ustekinumab | EMEA/H/C/005805 | Formycon AG | 2024/09/25 | Authorised |
| Vyloy | Human | zolbetuximab | zolbetuximab | EMEA/H/C/005868 | Astellas Pharma Europe B.V. | 2024/09/19 | Authorised |
| Tuznue | Human | trastuzumab | trastuzumab | EMEA/H/C/006252 | Prestige Biopharma Belgium | 2024/09/19 | Authorised |
| Anzupgo | Human | delgocitinib | Delgocitinib | EMEA/H/C/006109 | LEO Pharma A/S | 2024/09/19 | Authorised |
| Epruvy (previously Ranibizumab Midas) | Human | ranibizumab | ranibizumab | EMEA/H/C/006528 | Midas Pharma GmbH | 2024/09/19 | Authorised |
| Axitinib Accord | Human | axitinib | axitinib | EMEA/H/C/006206 | Accord Healthcare S.L.U. | 2024/09/19 | Authorised |
| Loqtorzi | Human | toripalimab | toripalimab | EMEA/H/C/006120 | Topalliance Biosciences Europe Limited | 2024/09/19 | Authorised |
| Iqirvo | Human | elafibranor | Elafibranor | EMEA/H/C/006231 | Ipsen Pharma | 2024/09/19 | Authorised |
| Kayfanda | Human | odevixibat | odevixibat sesquihydrate | EMEA/H/C/006462 | Ipsen Pharma | 2024/09/19 | Authorised |
| Ituxredi | Human | rituximab | rituximab | EMEA/H/C/006224 | Reddy Holding GmbH | 2024/09/19 | Authorised |
| Vevizye | Human | ciclosporin | ciclosporin | EMEA/H/C/006250 | Laboratoires Théa | 2024/09/19 | Authorised |
| Eksunbi | Human | ustekinumab | ustekinumab | EMEA/H/C/006448 | Samsung Bioepis NL B.V. | 2024/09/12 | Withdrawn |
| Winrevair | Human | sotatercept | sotatercept | EMEA/H/C/005647 | Merck Sharp & Dohme B.V. | 2024/08/22 | Authorised |
| Steqeyma | Human | ustekinumab | ustekinumab | EMEA/H/C/005918 | Celltrion Healthcare Hungary Kft. | 2024/08/22 | Authorised |
| Enzalutamide Viatris | Human | enzalutamide | enzalutamide | EMEA/H/C/006299 | Viatris Limited | 2024/08/22 | Authorised |
| Piasky | Human | crovalimab | Crovalimab | EMEA/H/C/006061 | Roche Registration GmbH | 2024/08/22 | Authorised |
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
药物在线相关数据库
